Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced synthetic therapies for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair. Imbed has a portfolio of products commercially available, and in development, based on its patented Microlyte® technology. Imbed Biosciences is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. For more information, please visit www.imbedbio.com, www.MicrolyteMatrix.com, facebook.com/imbedbio, and follow @ImbedBio and @MicroLyteAgMtrx on twitter.